Access Bio has ranked among the top searched stocks on 11 days in the past month.


As of 10:30 AM on the 20th, Access Bio is trading at 27,100 KRW, down 0.55% from the previous day. This represents a 22.9% decline compared to October 12. Access Bio is known as a specialized manufacturer of in vitro diagnostic products, including malaria diagnostic kits.

Over the past five days, individual investors have net purchased 317,943 shares, while foreigners and institutions have net sold 401,020 shares and 3,387 shares, respectively.


On October 13, Access Bio became a market issue with the headline "Surge following US approval of COVID-19 diagnostic kit."



※Source: AI Investment Assistant AI Lassi


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing